Irma Dominguez Vigil, MSc, PhD
Biography
Research & Publications
Locations
Biography
Irma Dominguez-Vigil earned her undergraduate degree in Pharmaceutical Biology and Chemistry at the School of Chemistry, from the Universidad Autonoma de Nuevo Leon (UANL) in Mexico (2013). She then obtained her Master’s degree in Pharmacy under the supervision of Dr. Benito Mata-Cardenas and Dr. Maria Camacho-Corona at the School of Chemistry, UANL (2015). Later, she earned a PhD degree in Molecular Biology and Genetic Engineering at the School of Medicine, UANL (2020), under the mentorship of Dr. Hugo A. Barrera-Saldana, where she explored genetic biomarkers using noninvasive techniques, such as liquid biopsies, as diagnostic tools for the early detection of gynecological cancers. During her doctoral studies, she obtained an International Academic Exchange Award (CONACyT) to Collaborate at Nuvance Health in Danbury, CT (2018-2020), where she worked with Patient Derived Cell Lines isolated from endometrial, ovarian, and sarcoma tumors as preclinical models for drug sensitivity. Presently, Dr. Dominguez-Vigil has been working on the effects of the small molecule CFI-400945 as an enhancer of radiation therapy in Non-small cell lung cancer (NSCLC) and exploring the interaction of STING with the response to DNA damaging therapy in Head and neck squamous cell carcinoma (HNSCC.
Education & Training
- PhDUniversidad Autonoma de Nuevo Leon, Molecular Biology and Genetic Engineering (2020)
- MScUniversidad Autonoma de Nuevo Leon, Pharmacy (2015)
- BScUniversidad Autonoma de Nuevo Leon, Pharmaceutical Biology and Chemistry (2013)
Activities
- PLK4 Inhibition as a Strategy to Enhance the Non-Small Cell Lung Cancer Radiation ResponseNew Haven, CT, United States 2022Radiobiology and Genome Integrity-Research Program
- Endometrial adenocarcinoma: relationship between tumor volume and its clinical-pathological characteristicsMonterrey, N.L., Mexico 2018XLV Congress of the National Academy of Medicine
- Epidemiology of Endometrial Cancer in a cohort of patients from the North East and Central MexicoCancún, Q.R., Mexico 2017XXII Latin American Conference of Gynecology & Obstetrics
- Isolation and Characterization of Tr-DNA from the urine of patients with Gynecological DiseasesEdinburg, TX, United States 2017Inaugural Research Symposium- The University of Texas Rio Grande Valley
- Monoterpenes as anti-Giardia agents: Activity of Citral, Geraniol and (-) CarvoneMonterrey, N.L., Mexico 2015XXVIII National Congress of Research in Medicine
- Antiprotozoan activity of Poliomintha GrayMonterrey, N.L., Mexico 2015III International Congress of Chemistry and Green Engineering
- In vitro anti-giadia activity of the hexane extract of Foeniculum vulgare and its main componentsMonterrey, N.L., Mexico 2015III International Congress of Chemistry and Green Engineering
- Anti-Giardia activity of the hexane extract of Citrus aurantifolia (Cristm) Swingle and some of its componentsMonterrey, N.L., Mexico 2014National Symposium of Pharmaceutical Sciences and Biomedicine
- Quantification of lead in popular candies of the metropolitan area of Monterrey, Nuevo LeonMonterrey, N.L., Mexico 2011International Congress of Pharmaceutical Biology and Chemists
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Academic Exchange Travel Award | CONACyT | 2018 |
Doctoral dissertation fellowship | CONACyT | 2015 |
Master dissertation fellowship | CONACyT | 2013 |
Professional Service
Organization | Role | Date |
---|---|---|
Pharmaceutical Biology | Reviewer | 2024 - Present |
Yale Postgraduate Association- 3rd Annual Symposium | Scientific Judge, 3rd Annual Symposium, Yale Postgraduate Association | 2023 - Present |
Yale Postdoctoral Association-Yale Buddy Program | Mentor | 2023 - Present |
Biopreservation and Biobanking | Reviewer | 2020 - Present |
Journal of Cancer Metastasis and Treatment | Reviewer | 2020 - Present |
Cancer Medicine | Reviewer | 2020 - Present |
Departments & Organizations
- Hayman Laboratory